Ota H.
- Country
- Czechia
- Department
- #3172:Kardiologie
Research Overview
- Rituximab in patients with ST-elevation myocardial infarction. A phase 2 placebo controlled randomized clinical trial. RITA-MI 2
- Efficacy of Dapagliflozin in Reducing Postoperative Atrial Fibrillation and Acute Kidney Injury in Patients Undergoing Coronary Artery Bypass Grafting
- Efficacy and Safety Evaluation of Subcutaneous Selatogrel in Preventing Recurrent Acute Myocardial Infarction in Post-AMI Patients
Data & Insights
Has run more than one trial at 407 of 994 partner sites.
Specializations
Cardiovascular Emergencies
This investigator specializes in the management of acute myocardial infarction and pulmonary embolism, with particular focus on innovative therapeutic approaches for emergency cardiac conditions.
- Catheter-directed thrombolysis techniques
- Emergency cardiac interventions
- Acute coronary syndromes
Their work encompasses both traditional and novel treatment strategies for life-threatening cardiovascular conditions.
Preventive Cardiology
The investigator focuses on atherosclerotic cardiovascular disease prevention and treatment, with emphasis on lipid management and innovative therapeutic agents.
- Lipoprotein management
- Plaque characteristics assessment
- Cardiovascular risk reduction
Their research explores new therapeutic pathways in cardiovascular disease prevention.
Post-Operative Cardiac Care
The investigator studies complications following coronary artery bypass surgery, particularly focusing on post-operative atrial fibrillation and kidney injury prevention.
- SGLT2 inhibitor applications
- Post-surgical complications
- Cardiac rhythm management
Their research aims to improve outcomes in cardiac surgery patients through targeted interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.